Dr. Nehal Lakhani, MD
Claim this profileSTART Midwest
Expert in Tumors
Studies Solid Tumors
23 reported clinical trials
28 drugs studied
About Nehal Lakhani, MD
Education:
- Graduated from Maharaja Sayajirao University-Baroda Medical College, India in 2000.
- Earned a Ph.D. in Pharmaceutical Sciences (Pharmacokinetics) from the National Institutes of Health – Medical College of Virginia Graduate Partnerships Program.
- Completed Residency in Internal Medicine at Michigan State University.
- Undertook a Fellowship in Hematology/Oncology at the National Cancer Institute/National Institutes of Health.
Experience:
- Board certified in Internal Medicine, Medical Oncology, and Hematology.
- Currently the Director of Clinical Research at START Midwest and a Medical Oncologist in Grand Rapids, Michigan.
- Authored and co-authored over 90 peer-reviewed publications.
- Member of professional organizations such as ASCO, AACR, and SITC.
Area of expertise
1Tumors
Global LeaderStage IV
Stage III
ARID1A positive
2Solid Tumors
Stage IV
Stage III
RET positive
Affiliated Hospitals
Clinical Trials Nehal Lakhani, MD is currently running
CC-94676
for Metastatic Castration-Resistant Prostate Cancer
This trial is testing a new drug called CC-94676 to see if it is safe and effective for men with advanced prostate cancer that continues to grow despite hormone-lowering treatments.
Recruiting1 award Phase 1
SGN-CEACAM5C
for Advanced Cancers
This trial is testing a new drug called SGN-CEACAM5C for patients with hard-to-treat solid tumors that have either returned or didn't respond to standard treatments. The drug targets cancer cells and kills them. The study will determine the safe dosage and effectiveness of the drug.
Recruiting1 award Phase 17 criteria
More about Nehal Lakhani, MD
Clinical Trial Related4 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Nehal Lakhani, MD has experience with
- Sym021
- Sym022
- Sym023
- Irinotecan Hydrochloride
- CPI-0209
- Upifitamab Rilsodotin
Breakdown of trials Nehal Lakhani, MD has run
Tumors
Solid Tumors
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nehal Lakhani, MD specialize in?
Nehal Lakhani, MD focuses on Tumors and Solid Tumors. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage III.
Is Nehal Lakhani, MD currently recruiting for clinical trials?
Yes, Nehal Lakhani, MD is currently recruiting for 8 clinical trials in Grand Rapids Michigan. If you're interested in participating, you should apply.
Are there any treatments that Nehal Lakhani, MD has studied deeply?
Yes, Nehal Lakhani, MD has studied treatments such as Sym021, Sym022, Sym023.
What is the best way to schedule an appointment with Nehal Lakhani, MD?
Apply for one of the trials that Nehal Lakhani, MD is conducting.
What is the office address of Nehal Lakhani, MD?
The office of Nehal Lakhani, MD is located at: START Midwest, Grand Rapids, Michigan 49546 United States. This is the address for their practice at the START Midwest.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.